BRIEF published on 08/06/2026 at 18:20, 23 days 3 hours ago BIOSYNEX SA victim of a cyberattack Security Data Cyberattack Health BIOSYNEX
BRIEF published on 07/22/2026 at 18:05, 1 month 7 days ago BIOSYNEX's half-year revenue is down Revenue BIOSYNEX Pharmacy Division Diagnostic Division Debt Rescheduling
BRIEF published on 06/11/2026 at 07:05, 2 months 18 days ago Biosynex finalizes the sale of its molecular biology business Restructuring Transfer BIOSYNEX Molecular Biology Rapid Diagnosis
BRIEF published on 06/11/2026 at 07:05, 2 months 18 days ago Biosynex sells its molecular biology business Strategic Growth Transfer BIOSYNEX Molecular Biology Rapid Diagnosis
BRIEF published on 05/25/2026 at 08:05, 3 months 4 days ago BIOSYNEX is considering the sale of its Molecular Biology business Pharmaceutical Industry Strategy Transfer BIOSYNEX Molecular Biology
BRIEF published on 05/25/2026 at 08:05, 3 months 4 days ago Biosynex sells its molecular biology business Transfer BIOSYNEX Molecular Biology Conditions Precedent Pharmaceutical Manufacturer
BRIEF published on 04/30/2026 at 18:05, 3 months 29 days ago BIOSYNEX SA: 2025 Annual Report and Outlook for 2026 EBITDA Revenue BIOSYNEX 2025 Results Outlook 2026
BRIEF published on 04/20/2026 at 18:50, 4 months 9 days ago BIOSYNEX postpones the publication of its 2025 annual accounts BIOSYNEX Backup Procedure Postponement Of Publication Health Diagnosis 2025 Annual Accounts
BRIEF published on 04/20/2026 at 18:50, 4 months 9 days ago BIOSYNEX postpones the publication of its 2025 annual accounts Financial Report Development Backup Annual Accounts BIOSYNEX
BRIEF published on 03/24/2026 at 09:02, 5 months 5 days ago BIOSYNEX SA: Extension of the observation period under safeguard Reorganization BIOSYNEX Backup Procedure Adjournment Debt Repayment Plan
Published on 08/29/2026 at 05:15, 16 hours 42 minutes ago Norsemont Announces Restatement of Financial Statements
Published on 08/29/2026 at 03:20, 18 hours 37 minutes ago BEACN Announces Financial Results for the Second Quarter of 2026
Published on 08/29/2026 at 01:15, 20 hours 42 minutes ago Gamma Resources Announces Increase in Private Placement to $1,750,000 and Closing of First Tranche at $872,500
Published on 08/29/2026 at 01:00, 20 hours 57 minutes ago Lobe Sciences Ltd. Announces Upsize to Non-Brokered Private Placement
Published on 08/28/2026 at 23:00, 22 hours 57 minutes ago Guanajuato Silver Grants Stock Options to Officer
Published on 08/29/2026 at 04:05, 17 hours 51 minutes ago INTCO Medical Reports 40.6% H1 2026 Revenue Growth, Expands World's Largest Disposable Glove Capacity to 107 Billion Pieces
Published on 08/28/2026 at 20:49, 1 day 1 hour ago Publication pursuant to Article 5(1)(b) and (3) of Regulation (EU) No. 596/2014 and Article 2(2) and (3) of the Commission Delegated Regulation (EU) No. 2016/1052 - Final Announcement
Published on 08/28/2026 at 20:42, 1 day 1 hour ago Aroundtown SA: Release of a capital market information
Published on 08/28/2026 at 19:10, 1 day 2 hours ago Invitation to Professional or Qualified Investors holding Notes to submit offers for Branicks Bridge Notes and VIB Bridge Notes
Published on 08/28/2026 at 18:01, 1 day 3 hours ago CPI Europe announces unaudited results for the first half of 2026
Published on 08/26/2026 at 18:02, 3 days 3 hours ago Altareit: Altarea press release regarding the Primonial matter
Published on 08/26/2026 at 18:00, 3 days 3 hours ago Altarea: Comprehensive settlement agreement reached, ending the dispute between Altarea and the shareholders of the Praemia group (formerly Primonial group)
Published on 08/25/2026 at 17:45, 4 days 4 hours ago CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
